PMID: 15948195

Quint A, Lerer I, Sagi M, Abeliovich D
Mutation spectrum in Jewish cystic fibrosis patients in Israel: implication to carrier screening.
Am J Med Genet A. 2005 Jul 30;136(3):246-8., 2005-07-30 [PubMed]
Sentences
No. Mutations Sentence Comment
6 ABCC7 p.Ile1234Val
X
ABCC7 p.Ile1234Val 15948195:6:141
status: NEW
view ABCC7 p.Ile1234Val details
We identified three mutations in two or more CF chromosomes, 2571 þ 1insT in Jews from Iraq, 3121-1G > A in patients from Kurdistan and I1234V in Yemenite Jewish patients. Login to comment
25 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 15948195:25:123
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 15948195:25:131
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15948195:25:139
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Ser549Arg
X
ABCC7 p.Ser549Arg 15948195:25:260
status: NEW
view ABCC7 p.Ser549Arg details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 15948195:25:273
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 15948195:25:304
status: NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 15948195:25:312
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Trp1089*
X
ABCC7 p.Trp1089* 15948195:25:296
status: NEW
view ABCC7 p.Trp1089* details
MUTATION ANALYSIS The following mutations are routinely tested in Jewish patients: the Ashkenazi founder mutations, DF508, W1282X, N1303K, G542X, 3849 þ 10 kb C!T, 1717-1G > A [Abeliovich et al., 1992], mutations commonly found in non-Ashkenazi patients, S549R (T!G), G85E, 405 þ 1G!A, W1089X, Y1092X, D1152H. Login to comment
26 ABCC7 p.Thr360Lys
X
ABCC7 p.Thr360Lys 15948195:26:10
status: NEW
view ABCC7 p.Thr360Lys details
ABCC7 p.Gln359Lys
X
ABCC7 p.Gln359Lys 15948195:26:4
status: NEW
view ABCC7 p.Gln359Lys details
The Q359K/T360K mutation is tested in patients from Georgia [Shoshani et al., 1993]. Login to comment
35 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 15948195:35:122
status: NEW
view ABCC7 p.Trp1282* details
The founder mutations in the Ashkenazi patients accounted for 98.5% of the CF-bearing chromosomes; the major mutation was W1282X representing 43% of the CF mutations while DF508 mutation represented 33.5%. Login to comment
36 ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 15948195:36:11
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15948195:36:4
status: NEW
view ABCC7 p.Gly542* details
The G542X, N1303K, 3849 þ 10 kb C!T, and 1717-1G!A mutations were found on 21.6% of the CF chromosomes. Login to comment
37 ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 15948195:37:61
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 15948195:37:238
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 15948195:37:306
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15948195:37:265
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Leu165Ser
X
ABCC7 p.Leu165Ser 15948195:37:51
status: NEW
view ABCC7 p.Leu165Ser details
In this group we revealed two additional mutations L165S and A455E, each was identified on a single chromosome and one mutation remained unidentified. The relative frequencies of the Ashkenazi founder mutations in Ashkenazi patients were W1282X (43%), DF508 (33%), G542X (10%), 3849 þ 10 kb C!T (5%), N1303K (5%), and 1717 (1%). Login to comment
42 ABCC7 p.Gly1244Glu
X
ABCC7 p.Gly1244Glu 15948195:42:14
status: NEW
view ABCC7 p.Gly1244Glu details
ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 15948195:42:4
status: NEW
view ABCC7 p.Leu997Phe details
ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 15948195:42:158
status: NEW
view ABCC7 p.Leu997Phe details
The L997F and G1244E mutations were identified following SSCP analysis, each on a single chromosome, and three alleles (9%) remain unidentified. The mutation L997F was described in patients with atypical CF [Castellani et al., 2001a,b] and patients with congenital absence of vas deferens [Dork et al., 1997] and it is debatable as to whether this is a CF-causing mutation or just a sequence variant. Login to comment
43 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 15948195:43:130
status: NEW
view ABCC7 p.Trp1282* details
We tested 12 CF chromosomes of Tunisian origin, eight (66.7%) possessed the 405 þ 1G!A mutation, three DF508 and one had the W1282X mutation. Login to comment
44 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 15948195:44:113
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15948195:44:128
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 15948195:44:199
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Trp1089*
X
ABCC7 p.Trp1089* 15948195:44:208
status: NEW
view ABCC7 p.Trp1089* details
Patients from the Balkan countries, Greece and Turkey (21 alleles), had some of the Ashkenazi founder mutations (W1282X, DF508, G542X, and 3849 þ 10 kb C!T), in addition to two other mutations, G85E and W1089X that were not found in Jewish patients from other origins. Login to comment
46 ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 15948195:46:54
status: NEW
view ABCC7 p.Tyr1092* details
Oriental Jews from Iraq (eight alleles) possessed the Y1092X mutation on three alleles. Login to comment
52 ABCC7 p.Thr360Lys
X
ABCC7 p.Thr360Lys 15948195:52:40
status: NEW
view ABCC7 p.Thr360Lys details
ABCC7 p.Gln359Lys
X
ABCC7 p.Gln359Lys 15948195:52:34
status: NEW
view ABCC7 p.Gln359Lys details
The patients from Georgia had the Q359K/T360K mutation on all their chromosomes. Login to comment
54 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 15948195:54:84
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Ile1234Val
X
ABCC7 p.Ile1234Val 15948195:54:13
status: NEW
view ABCC7 p.Ile1234Val details
Both had the I1234V mutation while the second mutation was DF508 in one patient and W1282X in the other. Login to comment
55 ABCC7 p.Ile1234Val
X
ABCC7 p.Ile1234Val 15948195:55:23
status: NEW
view ABCC7 p.Ile1234Val details
We also identified the I1234V mutation in a patient with CBAVD and IVS8-5T variant on the second chromosome. Login to comment
57 ABCC7 p.Ile1234Val
X
ABCC7 p.Ile1234Val 15948195:57:4
status: NEW
view ABCC7 p.Ile1234Val details
The I1234V mutation was described in Arab patients from the Arabian peninsula [Claustres et al., 1992; Kambouris et al., 2000] and several homozygous patients from a Beduin tribe in Qatar were described with variable clinical manifestations TABLE I. Login to comment
58 ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 15948195:58:891
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 15948195:58:279
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Gly1244Glu
X
ABCC7 p.Gly1244Glu 15948195:58:943
status: NEW
view ABCC7 p.Gly1244Glu details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 15948195:58:388
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15948195:58:417
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Ser549Arg
X
ABCC7 p.Ser549Arg 15948195:58:564
status: NEW
view ABCC7 p.Ser549Arg details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 15948195:58:597
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 15948195:58:659
status: NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 15948195:58:537
status: NEW
view ABCC7 p.Asp1152His details
ABCC7 p.Met952Ile
X
ABCC7 p.Met952Ile 15948195:58:838
status: NEW
view ABCC7 p.Met952Ile details
ABCC7 p.Ile1234Val
X
ABCC7 p.Ile1234Val 15948195:58:746
status: NEW
view ABCC7 p.Ile1234Val details
ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 15948195:58:917
status: NEW
view ABCC7 p.Leu997Phe details
ABCC7 p.Trp1089*
X
ABCC7 p.Trp1089* 15948195:58:687
status: NEW
view ABCC7 p.Trp1089* details
ABCC7 p.Thr360Lys
X
ABCC7 p.Thr360Lys 15948195:58:720
status: NEW
view ABCC7 p.Thr360Lys details
ABCC7 p.Gln359Lys
X
ABCC7 p.Gln359Lys 15948195:58:714
status: NEW
view ABCC7 p.Gln359Lys details
ABCC7 p.Leu165Ser
X
ABCC7 p.Leu165Ser 15948195:58:865
status: NEW
view ABCC7 p.Leu165Ser details
Mutations in the CF Bearing Alleles in the Jewish Patients According to the Ethnic Origin Country of origin Ashkenazi Morocco Tunisia Balkan Iraq Iran/ Kurdistan Georgia Yemen Total Number of alleles (%) 193 (69.0) 34 (12.1) 12 (4.3) 21 (7.5) 8 (2.8) 3 (0.7) 8 (2.8) 2 (0.7) 281 W1282X (%) 83 (42.8) 1 (8.3) 4 (19.0) 88 (31.3) DF508 (%) 65 (33.5) 24 (70.6) 3 (25.0) 7 (33.3) 1 100 (35.6) N1303K (%) 10 (5.2) 10 (3.6) G542X (%) 19 (10.3) 4 (19.0) 24 (8.5) 3849-10 kbC!T (%) 10 (5.1) 1 (2.9) 2 (9.5) 13 (4.6) 1717-1G!A (%) 2 (1.0) 2 (0.7) D1152H (%) 1 (0.5) 1 (0.4) S549R (T!G) (%) 4 (11.8) 4 (1.4) G85E (%) 2 (9.5) 2 (0.7) 405 þ 1G!A (%) 8 (66.7) 8 (2.8) Y1092X (%) 3 (37.5) 3 (1.1) W1089X (%) 2 (9.5) 2 (0.7) Q359K/T360K (%) 8 (100) 8 (2.8) I1234V (%) 2 (100) 2 (0.7) 2751 þ 1insT (%) 2 (25.0) 2 (0.7) 3121-1G > A (%) 1 1 (0.4) M952I (%) 1 (12.5) 1 (0.4) L165S (%) 1 (0.5) 1 (0.4) A455E (%) 1 (0.5) 1 (0.4) L997F (%) 1 (2.9) 1 (0.4) G1244E (%) 1 (2.9) 1 (0.4) Unkown (%) 1 (0.5) 3 (8.8) 2 (25.0) 1 7 (2.5) Mutation Spectrum in Jewish CF Patients [Wahab, 2003]. Login to comment
59 ABCC7 p.Ile1234Val
X
ABCC7 p.Ile1234Val 15948195:59:22
status: NEW
view ABCC7 p.Ile1234Val details
We found the mutation I1234V in 1 of 120 anonymous Yemenite Jews. Login to comment
61 ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 15948195:61:29
status: NEW
view ABCC7 p.Asp1152His details
The IVS-8 5T variant and the D1152H mutation are both common in the general Jewish population (Ashkenazi and non-Ashkenazi). Login to comment
62 ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 15948195:62:39
status: NEW
view ABCC7 p.Asp1152His details
It is important to note that while the D1152H mutation is common (0.9%) in the general Jewish population [Orgad et al., 2001], it is rare among patients with classical CF. Login to comment
65 ABCC7 p.Asp1152His
X
ABCC7 p.Asp1152His 15948195:65:33
status: NEW
view ABCC7 p.Asp1152His details
Therefore, we recommend that the D1152H mutation and IVS-8 5T variant not be included in the panel of mutations that are tested in the carrier-screening program, a recommendation that was adopted by the Israeli Medical Genetic Organization. Login to comment
69 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 15948195:69:107
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 15948195:69:115
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 15948195:69:123
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Ser549Arg
X
ABCC7 p.Ser549Arg 15948195:69:165
status: NEW
view ABCC7 p.Ser549Arg details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 15948195:69:178
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 15948195:69:209
status: NEW
view ABCC7 p.Tyr1092* details
ABCC7 p.Ile1234Val
X
ABCC7 p.Ile1234Val 15948195:69:260
status: NEW
view ABCC7 p.Ile1234Val details
ABCC7 p.Trp1089*
X
ABCC7 p.Trp1089* 15948195:69:201
status: NEW
view ABCC7 p.Trp1089* details
ABCC7 p.Thr360Lys
X
ABCC7 p.Thr360Lys 15948195:69:253
status: NEW
view ABCC7 p.Thr360Lys details
ABCC7 p.Gln359Lys
X
ABCC7 p.Gln359Lys 15948195:69:247
status: NEW
view ABCC7 p.Gln359Lys details
We suggest that 15 mutations that were found on two or more CF chromosomes from unrelated patients (DF508, W1282X, N1303K, G542X, 3849 þ 10 kb C!T, 1717-1 G!A, S549R (T!G), G85E, 405 þ 1G!A, W1089X, Y1092X, 2751 þ 1insT, 3121-1G!A, Q359K/T360K, I1234V) be tested in the CF screening of all Jewish individuals regardless of their origin. Login to comment